demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 outpatients
sofosbuvir and daclatasvir Roozbeh

1 studies excluded by filtering options 3

6516 Eslami, 2020 1310not a RCTrisk of bias not avaialble